III is dedicated to supporting research and building research capacity in infectious disease and immunity. The Institute has developed a number of strategic research initiatives to stimulate targeted areas where a need has been indentified. These initiatives usually involve community development activities and targeted funding opportunities. For information about III strategic initiatives, see the links below.

In this section:       

• Antibiotic Resistance
• Canadian Microbiome Initiative
• Hepatitis C Research Initiative
• HIV/AIDS Research Initiative
• Microbiologically Safe Food and Water
• Pandemic Preparedness Strategic Research Initiative
• SARS 
• Vaccines of the 21st Century